Evidence map›Paper›PMID 25358735›Full record

Trial reportInvestigative ophthalmology & visual science2014

Prediction accuracy of a novel dynamic structure-function model for glaucoma progression.

Rongrong Hu, Iván Marín-Franch, Lyne Racette

2 registry-linked trialsAbstract readClinical Trial
In one paragraph

Trial report in Investigative ophthalmology & visual science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00221897 recruitingnot on this map

Diagnostic Innovations in Glaucoma Study

TypeobservationalSponsorUniversity of California, San DiegoRan1995 to 2030Enrolled3,000ConditionsPrimary Open Angle Glaucoma, Myopia
NCT00221923 unknown statusnot on this map

African Descent and Glaucoma Evaluation Study (Formerly African Americans With Glaucoma Study)

TypeobservationalSponsorUniversity of California, San DiegoRan2002 to 2022Enrolled1,540ConditionsPrimary Open Angle Glaucoma
3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Structural endpoints for glaucoma studies].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019
    Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rongrong HuDepartment of Ophthalmology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Indiana University, Eugene and Marilyn Glick Eye Institute, Indianapolis, Indiana, United States.
Iván Marín-FranchDepartamento de Óptica, Facultad de Física, Universitat de València, Burjassot, Spain.
Lyne RacetteIndiana University, Eugene and Marilyn Glick Eye Institute, Indianapolis, Indiana, United States.

Funding

African Descent And Glaucoma Evaluation Study (ADAGES)U10EY014267 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 2002 to 2010
$13.2M
Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LINDA M ZANGWILL · 2012 to 2026
$10.3M
Diagnostic Innovations in Glaucoma:Structural AssessmentR01EY011008 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 1995 to 2015
$8.7M
APPLICATION OF PSYCHOPHYSICAL MODELS TO VISUAL DISORDERSR01EY007716 · NEI · TRUSTEES OF INDIANA UNIVERSITY · PI SWANSON, WILLIAM H. · 1997 to 2013
$4.7M
Diagnostic Innovations in Glaucoma Study (DIGS): Functional ImpairmentR01EY021818 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MEDEIROS, FELIPE · 2011 to 2015
$3.4M
African Descent and Glaucoma Evaluation (ADAGES) II: Glaucoma ProgressionR01EY019869 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 2010 to 2014
$2.8M
NEI NIH HHS EY019869NEI NIH HHS EY021818NEI NIH HHS EY11008NEI NIH HHS P30 EY022589NEI NIH HHS P30EY022589NEI NIH HHS R01 EY007716NEI NIH HHS R01 EY011008NEI NIH HHS R01 EY019869NEI NIH HHS R01 EY021818NEI NIH HHS U10 EY014267NEI NIH HHS U10EY14267
6 · The paper itself

Abstract

purposeTo assess the prediction accuracy of a novel dynamic structure-function (DSF) model to monitor glaucoma progression.

methodsLongitudinal data of paired rim area (RA) and mean sensitivity (MS) from 220 eyes with ocular hypertension or primary open-angle glaucoma enrolled in the Diagnostic Innovations in Glaucoma Study or the African Descent and Glaucoma Evaluation Study were included. Rim area and MS were expressed as percent of mean normal based on an independent dataset of 91 healthy eyes. The DSF model uses centroids as estimates of the current state of the disease and velocity vectors as estimates of direction and rate of change over time. The first three visits were used to predict the fourth visit; the first four visits were used to predict the fifth visit, and so on up to the 11th visit. The prediction error (PE) was compared to that of ordinary least squares linear regression (OLSLR) using Wilcoxon signed-rank test.

resultsFor predictions at visit 4 to visit 7, the average PE for the DSF model was significantly lower than OLSLR by 1.19% to 3.42% of mean normal. No significant difference was observed for the predictions at visit 8 to visit 11. The DSF model had lower PE than OLSLR for 70% of eyes in predicting visit 4 and approximately 60% in predicting visits 5, 6, and 7.

conclusionsThe two models had similar prediction capabilities, and the DSF model performed better in shorter time series. The DSF model could be clinically useful when only limited follow-ups are available. (ClinicalTrials.gov numbers, NCT00221923, NCT00221897.).

Indexed as

AgedBayes TheoremCase-Control StudiesDisease ProgressionFemaleGlaucoma, Open-AngleHumansLinear ModelsLongitudinal StudiesMaleMiddle AgedOcular HypertensionOptic DiskPredictive Value of TestsVisual FieldsVisual Field Testscomputational modelingglaucoma progressionstructure–function

Identifiers

PMID25358735
PMCPMC4266083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.